← SynDRA
tacrolimus
SynDRA canonical compound SYN0041754 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CYP3A5 | CYP3A7 | FKBP1A |
|---|
| Mechanism of action | calcineurin inhibitor |
|---|
| Indication | organ rejection |
|---|
| Disease area | transplant |
|---|
All known targets
- FKBP1A
- ABCG2
- IL2
- SF3B3
- PPP3CC
- PPP3CA
- MTOR
- KCNH2
- IL5
- IFNG
- CYP3A4
- FKBP5
Mechanisms of action (all sources)
- calcineurin inhibitor
- FKBP1A INHIBITOR
Drug classes
- Calcineurin Inhibitor Immunosuppressant
- Calcineurin Inhibitors
- Enzyme Inhibitors
- Immunologic Factors
- Immunosuppressive Agents
ATC classes
- OTHER DERMATOLOGICAL PREPARATIONS
- IMMUNOSUPPRESSANTS
Cross-references
Synonyms
- FK-506
- tacrolimus hydrate
- fujimycin
- tsukubaenolide
- anhydrous tacrolimus
- tacrolimus anhydrous
- modigraf
- FR900506
- Fujimycin
- Prograf
- Tsukubaenolide
- Protopic
- FK506
- Tacrolimus anhydrous
- Anhydrous Tacrolimus
- Modigraf
- FK 506
- Protopy
- LCP-Tacro
- Advagraf
- tacrolimus (fk506)
- FR-900506
- Tacrolimus, anhydrous
- 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
- Tacrolimus (INN)
- Astagraf XL
- Envarsus XR
- (-)-FK 506
- FK-506 (Tacrolimus)
- Prograf (TN)
- Tacrolimus [USAN]
- CHEMBL269732
- CHEBI:61049
- Y5L2157C4J
- NSC-758659
- K506
- NCGC00163470-03
- Prograft
- TACROLIMUS [INN]
Look up tacrolimus in the interactive SynDRA portal →